Stay updated with breaking news from Visual Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PRIME Designation Granted Based on Phase 2 ARCHER Trial Results, which Showed Meaningful Preservation of Visual Function in Patients with Geographic Atrophy ANX007 is the First Therapeutic...
Sweden: Postnatal supplementation with enteral arachidonic acid (AA)/docosahexaenoic acid (DHA) to extremely preterm (EPT) children did not significantly alter visual acuity (VA) at 2.5 years of...
ARCHER Trial Results Presented at ASRS Further Demonstrate Preservation of Visual Function in Patients with Geographic Atrophy; Company to Engage Regulatory Agencies to Determine Optimal Path Forward ...
Idiopathic intracranial hypertension was previously considered a rare condition, however, its prevalence is increasing in parallel with obesity in patient populations.
Dr. Jason Slakter of Vitreous Retina Macula Consultants of New York is the first to administer Syfovre, a groundbreaking treatment for geographic atrophy